Understanding what happens when you stop GHK-Cu helps you plan maintenance strategies
How It Works: What makes GHK-Cu unique is its multi-pathway approach
There is no established human dose for this blend, no completed human trial of any of the three compounds, and no safety data for the combination
Therefore, the PCAC meeting did not add any peptide to the list or create an immediate safe harbor for compounding
The scientific evidence for this is still developing, and many researchers find that the systemic effects from a subcutaneous injection are more than sufficient to target injuries anywhere in the body
Grgic, T., Banic, T., & Sikiric, P